MFDS — authorised 3 July 1979
- Marketing authorisation holder: JACOBUS
- Status: likely_approved
🇰🇷 Aczone in South Korea
MFDS authorised Aczone on 3 July 1979
Marketing authorisations
MFDS — authorised 4 April 2025
- Marketing authorisation holder: AUROBINDO PHARMA LTD
- Status: likely_approved
MFDS — authorised 23 April 2025
- Marketing authorisation holder: NOVITIUM PHARMA
- Status: likely_approved
Aczone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Aczone approved in South Korea?
Yes. MFDS authorised it on 3 July 1979; MFDS authorised it on 4 April 2025; MFDS authorised it on 23 April 2025.
Who is the marketing authorisation holder for Aczone in South Korea?
JACOBUS holds the South Korean marketing authorisation.